“…The 45 studies included nine on breast cancer (Garcia‐Closas et al, ; Haiman et al, ; Huo et al, ; Michailidou et al, , ; Palmer et al, ; Purrington et al, ) and, six on ovarian cancer (Bojesen et al, ; Earp et al, ; Kuchenbaecker et al, ; Lee et al, ; Phelan et al, ; Terry et al, ); five on lung cancer (Gao et al, ; Landi et al, ; Wang et al, ; Ye et al, ; Zhao et al, ). two each on glioma (Melin et al, ; Zhao et al, ), thyroid cancer (Gong et al, ; Gudmundsson et al, ), pancreatic cancer (Campa, Rizzato, et al, ; Petersen et al, ), prostate cancer (Panagiotou et al, ; Schumacher et al, ), colorectal cancer (Li et al, ; Pellatt, Wolff, Herrick, Lundgreen, & Slattery, ), RCC (Martino et al, ; Wu, Yan, et al, ), and leukemia (Sheng et al, ; Speedy et al, ); and one each on endometrial cancer (Prescott, McGrath, Lee, Buring, & De Vivo, ), bladder cancer (Rothman et al, ), testicular germ cell tumor (TGCTs) (Schumacher et al, ), melanoma (Llorca‐Cardenosa et al, ), multiple myeloma (Campa, Martino, et al, ), gastrointestinal stromal tumors (GISTs) (Zhang et al, ), non‐Hodgkin's lymphoma (NHL), diffuse Large B‐cell lymphoma (DLBCL), small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) (Shadrina et al, ), nasopharyngeal carcinoma (NPC) (Zhang et al, ), gastric cancer (Duan et al, ), esophageal cancer (Wu, Yan, et al, ), gastric cardia adenocarcinoma (GCA) (Zhang et al, ), hepatocellular carcinoma (HCC) (Zhang et al, ). One study focused on Caucasians (Prescott et al, ); two studies focused on Africans (Huo et al, ; Long et al, ); three studies on African‐Americans (Bojesen et al, ; Haiman et al, ; Palmer et al, ), 16 studies on Asians (Bojesen et al, ; Duan et al, ; Gao et al,…”